glp 1 blindness A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Can Ozempic-like Drugs Cause Blindness?

Moreover, pharmas didnt have an existing commercial force in obesity and lacked a clear playbook of how they might even go about commercializing such a drug

Another essential component concerns pharmacokinetics (PK) and pharmacodynamics (PD)

A direct head-to-head trial (NCT06662383, 800 patients) is underway with results in December 2026

The Favorable Impact of Gh-Igf1 on Radiation Damage Repair in Adjacent Tissues Radiotherapy could kill tumor cells and improve the survival rate of patients, but meanwhile cause inevitable damage to adjacent tissues in the radiotherapy area unavoidable

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Oral semaglutide (Rybelsus, Wegovy pill) should be taken daily in the morning, at least 30 minutes before drinking, eating, or taking other medications

The emergence of GLP-1 agonists like Ozempic is not only reshaping the landscape of weight management and diabetes treatment but also holds promise in addressing alcohol consumption and addiction